Xianbo Zhou

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

Emma Hockly, Victoria M. Richon, Benjamin Woodman et al. · Proceedings of the National Academy of Sciences · 2003 · 836 citations · Full text

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin

Lisa M. Butler, Xianbo Zhou, Weisheng Xu et al. · Proceedings of the National Academy of Sciences · 2002 · 506 citations · Full text

Cloning and characterization of a histone deacetylase, HDAC9

Xianbo Zhou, Paul A. Marks, Richard A. Rifkind et al. · Proceedings of the National Academy of Sciences · 2001 · 238 citations · Full text

Histone Modifications, Epigenetic Change, Genetics +18

Epigallocatechin-3-gallate (EGCG)-Stabilized Selenium Nanoparticles Coated with Tet-1 Peptide To Reduce Amyloid-β Aggregation and Cytotoxicity

Jingnan Zhang, Xianbo Zhou, Qianqian Yu et al. · ACS Applied Materials & Interfaces · 2014 · 194 citations

Nanoparticles, Nanotherapeutics, Engineering +19

Sialic acid (SA)-modified selenium nanoparticles coated with a high blood–brain barrier permeability peptide-B6 peptide for potential use in Alzheimer’s disease

Tiantian Yin, Licong Yang, Yanan Liu et al. · Acta Biomaterialia · 2015 · 189 citations

Nanoparticles, Nanomedicine, Neurodegenerative Diseases +12